Metabolomics as a tool to predict the risk of decompensation or liver-related death in patients with compensated cirrhosis.
Hepatology (Baltimore, Md.)（2023）
摘要
In patients with compensated cirrhosis and CSPH, metabolomics improves the capacity of clinical models and achieves similar predictive capacity than models including HVPG.
更多查看译文
关键词
metabolomics,decompensation,liver-related
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要